AIBioTech(R) Acquires ImmunoTox(R) Inc Adding Immunotoxicology and Immunopharmacological Assessments to Its Research Support Services RICHMOND, Va., March 20, 2014 (GLOBE NEWSWIRE) -- AIBioTech has acquired ImmunoTox Inc, a Richmond-based, contract research firm that focuses on immunotoxicology and immunopharmacology studies done...

Photo Release -- AIBioTech Executive VP to Present Largest Pharmacogenomic Study to Date at IONWorld2013 RICHMOND, Va., Oct. 15, 2013 (GLOBE NEWSWIRE) -- AIBioTech Co-Founder and Executive Vice President Thomas Reynolds will present the results of a novel multiplex pharmacogenomics panel and accompanying...

AIBioTech(R) Receives Subcontract Award From DynPort Vaccine Company LLC, for Continued Development and FDA Approval of a Nerve Agent Prophylactic RICHMOND, Va., May 23, 2013 (GLOBE NEWSWIRE) -- AIBioTech is pleased to announce receipt of a firm fixed price subcontract from DynPort Vaccine Company LLC (DVC), a CSC company, valued at nearly $3...